CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes

Posted: December 25, 2024 at 2:51 am

CORXEL expands its cardiometabolic pipeline into obesity and diabetes CORXEL expands its cardiometabolic pipeline into obesity and diabetes

See more here:
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes

Related Posts